K051969

Substantially Equivalent

TRICAT RIA (ADRENALIN/NORADRENALIN/DOPAMINE); KATCOMBI RIA (ADRENALIN/NORADRENALIN); NORADRENALIN RIA

Applicant: Ibl GmbH
Product code: CHQ
Advisory panel: Clinical Chemistry
Date received: 2005-07-20
Decision date: 2005-10-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: East Stroudsburg, PA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.